Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
1 other identifier
observational
252
1 country
1
Brief Summary
Primary Objectives:
- 1.To determine whether high-risk sexual behaviors are more common in patients with oropharyngeal cancer than in patients with head and neck cancers of other sub-sites.
- 2.To determine if high-risk sexual behaviors are more common in patients with HPV (human papillomavirus) associated head and neck cancer than those without evidence of HPV-16 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
July 25, 2007
CompletedFirst Posted
Study publicly available on registry
July 27, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedJuly 30, 2012
July 1, 2012
3.8 years
July 25, 2007
July 27, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Responders with High-risk Sexual Behaviors
Written self-administered questionnaire responses analyzed to determine whether patients with oropharyngeal cancer have history of high-risk sexual behavior (defined as 15 or more lifetime sexual partners) greater than that of patients with tumors of other sites of head and neck
1 month for mailing and return of questionnaires
Study Arms (2)
Patients with Oropharyngeal Cancer
Patients with Non-Oropharyngeal Cancer
Interventions
The questionnaire contains 23 questions and is estimated to take approximately 10 minutes to complete.
Eligibility Criteria
Patients with diagnosed squamous cell carcinoma of the head and neck that participated in the molecular epidemiology study LAB00-062 of head and neck cancer between 1995 and 2005.
You may qualify if:
- Patients with diagnosed squamous cell carcinoma of the head and neck that participated in the molecular epidemiology study LAB00-062 of head and neck cancer between 1995 and 2005.
- Head and Neck cancer participants of LAB00-062 that are still alive.
- Head and Neck cancer participants of LAB00-062 that have known mailing addresses in the U.S.A.
- Patients must be 18 years and older.
- Patients will have completed their primary treatment but may be undergoing treatment for a second primary or recurrent disease.
- Ability to read, write, and speak Spanish or English.
You may not qualify if:
- n/a
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erich Sturgis, MD
UT MD Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2007
First Posted
July 27, 2007
Study Start
March 1, 2006
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
July 30, 2012
Record last verified: 2012-07